A Phase 1 Study of Safety and Pharmacokinetics of BKR-017 in Individuals on Statin Therapy
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
View:
• Men and women, ages 18-70 inclusive
• Subjects currently on statin treatments.
Locations
United States
Louisiana
Pennington Biomedical Research Center
RECRUITING
Baton Rouge
Contact Information
Primary
Roger D Nolan, PhD
roger.nolan@biokier.com
919-270-2361
Backup
Jerzy Szewczyk, PhD
george.szewczyk@biokier.com
919-323-6497
Time Frame
Start Date: 2025-07-16
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 10
Related Therapeutic Areas
Sponsors
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Leads: BioKier Inc.